These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 19821794)

  • 21. The prevalence of small intestinal bacterial vergrowth in irritable bowel syndrome.
    Mann NS; Limoges-Gonzales M
    Hepatogastroenterology; 2009; 56(91-92):718-21. PubMed ID: 19621689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perceived food intolerance and irritable bowel syndrome in a population 3 years after a giardiasis-outbreak: a historical cohort study.
    Litleskare S; Wensaas KA; Eide GE; Hanevik K; Kahrs GE; Langeland N; Rortveit G
    BMC Gastroenterol; 2015 Nov; 15():164. PubMed ID: 26585714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Post-infectious gastrointestinal symptoms after acute Giardiasis. A 1-year follow-up in general practice.
    Wensaas KA; Langeland N; Rortveit G
    Fam Pract; 2010 Jun; 27(3):255-9. PubMed ID: 20308244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The use of bismuth tripotassium dicitrate (De-Nol), a promising line of pathogenetic therapy for irritated bowel syndrome with diarrhea].
    Iakovenko EP; Agafonova NA; Pokhal'skaia OIu; Kolganova AV; Nazarbekova RS; Ivanov AN; Davletshina IV; Popova EV; Prianishnikova AS; Ovchinnikova NI; Iakovenko AV; Aldiiarova MA; D'iachkoava AV; Gioeva IZ
    Klin Med (Mosk); 2008; 86(10):47-52. PubMed ID: 19069460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of predominant methanogenic flora on the outcome of lactose breath test in irritable bowel syndrome patients.
    Vernia P; Camillo MD; Marinaro V; Caprilli R
    Eur J Clin Nutr; 2003 Sep; 57(9):1116-9. PubMed ID: 12947430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of irritable bowel syndrome with Escherichia coli strain Nissle 1917 (EcN): a retrospective survey].
    Plassmann D; Schulte-Witte H
    Med Klin (Munich); 2007 Nov; 102(11):888-92. PubMed ID: 17992479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peppermint oil (Mintoil) in the treatment of irritable bowel syndrome: a prospective double blind placebo-controlled randomized trial.
    Cappello G; Spezzaferro M; Grossi L; Manzoli L; Marzio L
    Dig Liver Dis; 2007 Jun; 39(6):530-6. PubMed ID: 17420159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bacterial overgrowth as a cause of irritable bowel syndrome.
    Riordan SM; Kim R
    Curr Opin Gastroenterol; 2006 Nov; 22(6):669-73. PubMed ID: 17053447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study.
    Guglielmetti S; Mora D; Gschwender M; Popp K
    Aliment Pharmacol Ther; 2011 May; 33(10):1123-32. PubMed ID: 21418261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breath testing to evaluate lactose intolerance in irritable bowel syndrome correlates with lactulose testing and may not reflect true lactose malabsorption.
    Pimentel M; Kong Y; Park S
    Am J Gastroenterol; 2003 Dec; 98(12):2700-4. PubMed ID: 14687820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reassessment of the role of methane production between irritable bowel syndrome and functional constipation.
    Furnari M; Savarino E; Bruzzone L; Moscatelli A; Gemignani L; Giannini EG; Zentilin P; Dulbecco P; Savarino V
    J Gastrointestin Liver Dis; 2012 Jun; 21(2):157-63. PubMed ID: 22720304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome.
    Zeng J; Li YQ; Zuo XL; Zhen YB; Yang J; Liu CH
    Aliment Pharmacol Ther; 2008 Oct; 28(8):994-1002. PubMed ID: 18671775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Giardia lamblia infection in patients with irritable bowel syndrome and dyspepsia: a prospective study.
    Grazioli B; Matera G; Laratta C; Schipani G; Guarnieri G; Spiniello E; Imeneo M; Amorosi A; Focà A; Luzza F
    World J Gastroenterol; 2006 Mar; 12(12):1941-4. PubMed ID: 16610003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fructose malabsorption and symptoms of irritable bowel syndrome: guidelines for effective dietary management.
    Shepherd SJ; Gibson PR
    J Am Diet Assoc; 2006 Oct; 106(10):1631-9. PubMed ID: 17000196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of a proprietary Bacillus coagulans preparation on symptoms of diarrhea-predominant irritable bowel syndrome.
    Dolin BJ
    Methods Find Exp Clin Pharmacol; 2009 Dec; 31(10):655-9. PubMed ID: 20140275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intestinal gas in plain abdominal radiographs does not correlate with symptoms after lactulose challenge.
    Morken MH; Berstad AE; Nysaeter G; Berstad A
    Eur J Gastroenterol Hepatol; 2007 Jul; 19(7):589-93. PubMed ID: 17556907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence of post-infectious irritable bowel syndrome and functional intestinal disorders following a water-borne viral gastroenteritis outbreak.
    Zanini B; Ricci C; Bandera F; Caselani F; Magni A; Laronga AM; Lanzini A;
    Am J Gastroenterol; 2012 Jun; 107(6):891-9. PubMed ID: 22525306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of bacterial overgrowth in IBS using the lactulose H2 breath test: comparison with 14C-D-xylose and healthy controls.
    Walters B; Vanner SJ
    Am J Gastroenterol; 2005 Jul; 100(7):1566-70. PubMed ID: 15984983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
    Ducrotte P; Dapoigny M; Bonaz B; Siproudhis L
    Aliment Pharmacol Ther; 2005 Feb; 21(4):435-44. PubMed ID: 15709995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome.
    Nobaek S; Johansson ML; Molin G; Ahrné S; Jeppsson B
    Am J Gastroenterol; 2000 May; 95(5):1231-8. PubMed ID: 10811333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.